Subscribe to our Newsletters !!
The connection between genes and traits is one of
Our customers depend on the high performance and r
Few names in the medical history have had a profou
Alembic Pharmaceuticals Limited appoints Mr. Manis
Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and her
It is important to understand that natural remedie
Dear Readers, Welcome to the latest issue of The Magazine
Drug major Glenmark Pharma on Thursday said it has received final acceptance from the US health regulator for central nervous system stimulant medication Amphetamine Sulfate tablets.
The approved product is a generic version of Evekeo tablets of Arbor Pharmaceuticals LLC.
Quoting IQVIA sales statistics for the 12 month period ending November 2020, Glenmark said Evekeo Tablets, 5 mg and 10 mg marketplace achieved annual sales of approximately USD 21.5 million.
Glenmark”s current portfolio consists of 168 products authorised for distribution in the US market and 43 ANDA”s pending approval with the USFDA.
Shares of Glenmark Pharma were trading 1.44 per cent lower at Rs 478.50 apiece on BSE.